triazoles has been researched along with Weight Gain in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 9 (31.03) | 29.6817 |
| 2010's | 16 (55.17) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Abizaid, A; Edwards, A; Hay, RE; Hill, MN; Hyland, L; Karatsoreos, I; Klein, M; MacDonald, D | 1 |
| Bickel, M; Cahn, P; Greaves, W; Johnson, M; Kumar, P; Molina, JM; Morais, C; Rizzardini, G; Sklar, P; Wan, H; Xu, ZJ | 1 |
| Anvar, AR; Hernández-Carretero, A; Rivera, AJ; Skarra, DV; Thackray, VG | 1 |
| Fathy, A; Khashab, S; Shaheen, N; Soliman, AR; Soliman, MA | 1 |
| Currie, RA; Goetz, AK; Goodman, JI; Omiecinski, CJ; Peffer, RC | 1 |
| Kabbara, WK; Ramadan, WH | 1 |
| Diamanti-Kandarakis, E; Motta, AB; Sir-Petermann, T; Spritzer, PM | 1 |
| Costa, NO; Gerardin, DC; Mesquita, Sde F; Montagnini, BG; Pereira, MR; Sgarioni, V; Vieira, ML | 1 |
| Aguilera-Lizarraga, J; Blanco, JR; Oteo, JA; Pérez-Martínez, L; Pérez-Matute, P | 1 |
| Awad, P; Delarue, G; Fraillon, F; Nélieu, S; Ollivier, E; Pelosi, C | 1 |
| Blanco, JR; Iñiguez, M; Oteo, JA; Pérez-Martínez, L; Pérez-Matute, P; Pichel, JG; Recio-Fernández, E; Torrens, R | 1 |
| Balaji, B; M, SS; Rajan, RK | 1 |
| Engel, SS; Goldstein, BJ; Golm, GT; Kaufman, KD; Seck, TL; Sisk, CM; Wang, H; Williams-Herman, DE | 1 |
| Alonso, M; Bermúdez-Silva, FJ; Crespillo, A; Decara, J; Goya, P; Hernandez-Folgado, L; Jagerovic, N; Macías-González, M; Pavón, FJ; Perez-Valero, V; Reyes-Cabello, C; Rodríguez de Fonseca, F; Serrano, A; Suárez, J; Vida, M | 1 |
| Scheen, AJ | 1 |
| Cuzick, J; Dowsett, M; Forbes, JF; Harvie, M; Howell, A; Sestak, I | 1 |
| Fukuda, K; Itoh, H; Kawai, T; Matsuhashi, T; Meguro, S; Mogi, S; Sano, M; Suzuki, Y | 1 |
| Katz, DP; Sample, CH; Swithers, SE | 1 |
| Gupta, S; Masand, PS | 1 |
| Chiorato, S; de Castro, VL; Goes, K | 1 |
| Ayanoglu, E; Brennan, RJ; Corton, JC; Dix, DJ; Hu, W; Kavlock, RJ; Lau, C; Martin, MT; Ren, H; Wood, CR | 1 |
| Alcin, E; Aydin, M; Nedzvetsky, VS; Sahin, Z; Tuzcu, M; Yilmaz, B | 1 |
| Wengström, Y | 1 |
| Chen, RZ; Clements, MJ; Fong, TM; Frassetto, A; Hale, JJ; Huang, RR; Lao, JZ; Tong, X; Walsh, TF; Wang, J; Xiao, JC | 1 |
| Hall, IH; Izydore, RA; Simlot, R; Wong, OT | 1 |
| Kaplita, SB; Marcus, RN; Roberts, DL; Robinson, DS; Seminara, JA; Smith, JM; Stringfellow, JC | 1 |
| Palmer, C; Roberts, RL; Viswanath, M | 1 |
| Bikoff, J; Ginsberg, DL; Sussman, N | 1 |
7 review(s) available for triazoles and Weight Gain
| Article | Year |
|---|---|
Sitagliptin/Simvastatin: a first combination tablet to treat type 2 diabetes and hypercholesterolemia--a review of its characteristics.
Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypoglycemia; Polypharmacy; Pyrazines; Risk Factors; Simvastatin; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Weight Gain | 2015 |
Novel strategies in the management of polycystic ovary syndrome.
Topics: Adult; Clomiphene; Contraceptives, Oral, Combined; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropins; Hirsutism; Humans; Infertility, Female; Letrozole; Life Style; Menstruation Disturbances; Metformin; Nitriles; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Precision Medicine; Pregnancy; Selective Estrogen Receptor Modulators; Triazoles; Weight Gain; Weight Loss | 2015 |
DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials.
Topics: Adamantane; Clinical Trials as Topic; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Linagliptin; Male; Metformin; Nitriles; Piperidines; Purines; Pyrazines; Pyrrolidines; Quinazolines; Sitagliptin Phosphate; Triazoles; Uracil; Vildagliptin; Weight Gain | 2012 |
Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Drug Interactions; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Triazoles; Venlafaxine Hydrochloride; Weight Gain | 2002 |
Effectively nursing patients receiving aromatase inhibitor therapy.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Arthralgia; Atrophy; Breast Neoplasms; Cardiovascular Diseases; Comorbidity; Female; Hot Flashes; Humans; Lubricants; Neoplasm Recurrence, Local; Nitriles; Patient Education as Topic; Quality of Life; Tamoxifen; Triazoles; Vagina; Weight Gain | 2008 |
The safety profile of nefazodone.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Depressive Disorder; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Mixed Function Oxygenases; Piperazines; Placebos; Sexual Dysfunctions, Psychological; Treatment Outcome; Triazoles; Weight Gain | 1996 |
Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Weight; Controlled Clinical Trials as Topic; Depressive Disorder; Female; Humans; Imipramine; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome; Triazoles; Weight Gain | 2001 |
3 trial(s) available for triazoles and Weight Gain
| Article | Year |
|---|---|
Brief Report: Switching to DOR/3TC/TDF Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT Trial.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Pyridones; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Triazoles; Weight Gain; Weight Loss | 2021 |
Sitagliptin might be a favorable antiobesity drug for new onset diabetes after a renal transplant.
Topics: Adult; Anti-Obesity Agents; Blood Glucose; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin Glargine; Insulin, Long-Acting; Kidney Transplantation; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Weight Gain; Weight Loss | 2013 |
Sitagliptin more effectively achieves a composite endpoint for A1C reduction, lack of hypoglycemia and no body weight gain compared with glipizide.
Topics: Aged; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glipizide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles; Weight Gain | 2011 |
19 other study(ies) available for triazoles and Weight Gain
| Article | Year |
|---|---|
Ghrelin Receptor Signaling Is Not Required for Glucocorticoid-Induced Obesity in Male Mice.
Topics: Adiposity; Animals; Eating; Glucocorticoids; Glycine; Hippocampus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Prefrontal Cortex; Receptors, Ghrelin; Triazoles; Weight Gain | 2020 |
Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin Resistance.
Topics: Animals; Eating; Energy Metabolism; Female; Glucose; Hyperandrogenism; Hyperinsulinism; Insulin Resistance; Letrozole; Mice; Mice, Inbred C57BL; Nitriles; Obesity; Sexual Maturation; Triazoles; Weight Gain | 2017 |
Phenobarbital and propiconazole toxicogenomic profiles in mice show major similarities consistent with the key role that constitutive androstane receptor (CAR) activation plays in their mode of action.
Topics: Animals; Carcinogenicity Tests; Carcinogens; Cell Proliferation; Constitutive Androstane Receptor; Female; Fungicides, Industrial; Genes, Reporter; Hepatocytes; Hypnotics and Sedatives; Male; Mice; Neoplasms, Experimental; Organ Size; Phenobarbital; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Toxicogenetics; Triazoles; Weight Gain | 2014 |
Evaluation of the reproductive toxicity of fungicide propiconazole in male rats.
Topics: Animals; Cell Shape; Endocrine Disruptors; Estradiol; Fungicides, Industrial; Male; Organ Size; Rats, Wistar; Reproduction; Sexual Behavior, Animal; Sperm Count; Spermatozoa; Testis; Testosterone; Triazoles; Vas Deferens; Weight Gain | 2015 |
Maraviroc modifies gut microbiota composition in a mouse model of obesity: a plausible therapeutic option to prevent metabolic disorders in HIV-infected patients.
Topics: Animals; Bacterial Translocation; Bacteroidetes; CCR5 Receptor Antagonists; Cecum; Cyclohexanes; Diet, High-Fat; Drug Evaluation, Preclinical; Firmicutes; HIV Fusion Inhibitors; HIV Infections; Humans; Insulin Resistance; Male; Maraviroc; Metabolic Diseases; Mice; Mice, Inbred C57BL; Microbiota; Non-alcoholic Fatty Liver Disease; Obesity; Proteobacteria; Random Allocation; Species Specificity; Triazoles; Weight Gain | 2015 |
Evaluation of epoxiconazole bioavailability in soil to the earthworm Aporrectodea icterica.
Topics: Animals; Biological Availability; Environmental Monitoring; Epoxy Compounds; Fungicides, Industrial; Oligochaeta; Soil; Soil Pollutants; Triazoles; Weight Gain | 2016 |
Maraviroc ameliorates the increased adipose tissue macrophage recruitment induced by a high-fat diet in a mouse model of obesity.
Topics: Adipose Tissue; Animals; Anti-HIV Agents; CCR5 Receptor Antagonists; Chemokine CCL2; Cyclohexanes; Cytokines; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation; Humans; Insulin Resistance; Macrophages; Male; MAP Kinase Kinase 4; Maraviroc; Mice; Mice, Inbred C57BL; Obesity; Triazoles; Weight Gain | 2017 |
Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Androgen Antagonists; Animals; Antioxidants; Biomarkers; Blood Glucose; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrous Cycle; Female; Glycine max; Isoflavones; Letrozole; Nitriles; Ovary; Oxidative Stress; Phytoestrogens; Phytotherapy; Plants, Medicinal; Polycystic Ovary Syndrome; Rats, Sprague-Dawley; Testosterone; Time Factors; Triazoles; Uterus; Weight Gain | 2017 |
I read about a new drug for diabetes called Januvia. Should I be interested in it?
Topics: Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Humans; Pyrazines; Sitagliptin Phosphate; Triazoles; Weight Gain | 2009 |
Anti-obesity efficacy of LH-21, a cannabinoid CB(1) receptor antagonist with poor brain penetration, in diet-induced obese rats.
Topics: Animals; Anti-Obesity Agents; Brain; Diet, High-Fat; Eating; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Gene Expression; HEK293 Cells; Humans; Intra-Abdominal Fat; Leptin; Lipogenesis; Liver; Male; Mice; Mice, Knockout; Obesity; PPAR alpha; PPAR gamma; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Triazoles; Weight Gain | 2012 |
Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Female; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Tamoxifen; Triazoles; Weight Gain | 2012 |
A new preventive strategy for hypoglycemia incorporating added food diet in patients with type 2 diabetes who received sitagliptin therapy.
Topics: Aged; Blood Glucose; Blood Pressure; Cholesterol, HDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Eating; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Lipids; Male; Middle Aged; Pyrazines; Severity of Illness Index; Sitagliptin Phosphate; Sulfonylurea Compounds; Treatment Outcome; Triazoles; Weight Gain | 2012 |
Influence of ovarian and non-ovarian estrogens on weight gain in response to disruption of sweet taste--calorie relations in female rats.
Topics: Anastrozole; Animals; Aromatase Inhibitors; Body Weight; Energy Intake; Energy Metabolism; Female; Nitriles; Ovariectomy; Rats; Rats, Sprague-Dawley; Saccharin; Sweetening Agents; Taste; Triazoles; Weight Gain | 2013 |
Developmental toxicity potential of paclobutrazol in the rat.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Animals, Newborn; Female; Fetal Development; Male; Pregnancy; Rats; Rats, Wistar; Reproduction; Triazoles; Weight Gain | 2004 |
Toxicogenomic study of triazole fungicides and perfluoroalkyl acids in rat livers predicts toxicity and categorizes chemicals based on mechanisms of toxicity.
Topics: Animals; Biomarkers; Chemical and Drug Induced Liver Injury; Fluorocarbons; Fungicides, Industrial; Hormones; Liver; Male; Oligonucleotide Array Sequence Analysis; Organ Size; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Testosterone; Thyroid Hormones; Triazoles; Weight Gain | 2007 |
Effects of letrozole on hippocampal and cortical catecholaminergic neurotransmitter levels, neural cell adhesion molecule expression and spatial learning and memory in female rats.
Topics: Animals; Aromatase Inhibitors; Blotting, Western; Catecholamines; Cerebral Cortex; Chromatography, High Pressure Liquid; Densitometry; Dopamine; Electrochemistry; Estradiol; Female; Hippocampus; Learning; Letrozole; Maze Learning; Memory; Neural Cell Adhesion Molecules; Neurotransmitter Agents; Nitriles; Norepinephrine; Organ Size; Ovariectomy; Ovary; Parasympathetic Nervous System; Rats; Space Perception; Triazoles; Uterus; Weight Gain | 2008 |
Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor.
Topics: Animals; Anti-Obesity Agents; Binding, Competitive; Blood-Brain Barrier; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Dose-Response Relationship, Drug; Drug Inverse Agonism; Eating; Humans; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Binding; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recombinant Proteins; Transfection; Triazoles; Weight Gain | 2008 |
Hypolipidemic activity of 4-substituted 1,2-diacyl-1,2,4-triazolidine-3,5-diones in rodents.
Topics: Animals; Aorta; Eating; Enzyme Inhibitors; Feces; Hypolipidemic Agents; Intestine, Small; Lipoproteins; Liver; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred Strains; Rats; Rats, Sprague-Dawley; Spectrophotometry, Infrared; Triazoles; Triglycerides; Weight Gain | 1994 |
Reduction of hypoxic-ischemic brain swelling in the neonatal rat with PAF antagonist WEB 2170: lack of long-term protection.
Topics: Animals; Animals, Newborn; Atrophy; Azepines; Brain; Brain Edema; Female; Hypoxia-Ischemia, Brain; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Triazoles; Weight Gain | 2000 |